KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoansLoans - NetNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesRetained EarningsSecurities - Held-to-maturitySecurities - TradableSecurities BorrowedSecurities BoughtShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morgan Stanley (MS) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Morgan Stanley (MS) over the last 13 years, with Q3 2025 value amounting to $103.7 billion.

  • Morgan Stanley's Cash & Equivalents rose 1388.83% to $103.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $103.7 billion, marking a year-over-year increase of 1388.83%. This contributed to the annual value of $105.4 billion for FY2024, which is 1810.34% up from last year.
  • Latest data reveals that Morgan Stanley reported Cash & Equivalents of $103.7 billion as of Q3 2025, which was up 1388.83% from $109.1 billion recorded in Q2 2025.
  • Over the past 5 years, Morgan Stanley's Cash & Equivalents peaked at $136.1 billion during Q1 2022, and registered a low of $89.2 billion during Q4 2023.
  • In the last 5 years, Morgan Stanley's Cash & Equivalents had a median value of $109.1 billion in 2025 and averaged $111.0 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 3069.58% in 2021, then crashed by 3035.66% in 2023.
  • Quarter analysis of 5 years shows Morgan Stanley's Cash & Equivalents stood at $127.7 billion in 2021, then rose by 0.31% to $128.1 billion in 2022, then plummeted by 30.36% to $89.2 billion in 2023, then rose by 18.1% to $105.4 billion in 2024, then decreased by 1.57% to $103.7 billion in 2025.
  • Its Cash & Equivalents was $103.7 billion in Q3 2025, compared to $109.1 billion in Q2 2025 and $90.7 billion in Q1 2025.